SCHEMBL3531201

SCHEMBL3531201

N#Cc1ccccc1NC(=O)c1ccc(N)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.53
ALDH1A1 P00352 6/20 0.53
GAA P10253 4/20 0.53
HPGD P15428 3/20 0.53
JAK2 O60674 1/20 0.51
TYK2 P29597 1/20 0.51
KMT2A Q03164 4/20 0.50
MEN1 O00255 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
TSHR P16473 2/20 0.50
MAPT P10636 2/20 0.50
MAPK1 P28482 1/20 0.50
TAS1R3 Q7RTX0 1/20 0.50
TAS1R1 Q7RTX1 1/20 0.50
TAS1R2 Q8TE23 1/20 0.50
RAB9A P51151 5/20 0.49
NPC1 O15118 4/20 0.49
HSD17B10 Q99714 3/20 0.49
ALOX15 P16050 2/20 0.49
HTT P42858 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18147739 0.90 KDM4E (0.53) KDM4EALDH1A1GAAHPGDKMT2A
SCHEMBL3533243 0.80 MAPT (0.58) ALDH1A1GAAKMT2AMEN1SMN1; SMN2
SCHEMBL25395048 0.80 MAPT (0.66) KDM4EALDH1A1HPGDJAK2TYK2
SCHEMBL10154365 0.77 RAB9A (0.57) KDM4EALDH1A1GAAKMT2AMEN1
SCHEMBL8311977 0.76 JAK2 (0.73) KDM4EALDH1A1GAAJAK2TYK2
SCHEMBL11219138 0.75 RAB9A (0.67) KDM4EALDH1A1JAK2TYK2KMT2A
SCHEMBL29459607 0.75 RAB9A (0.67) KDM4EALDH1A1JAK2TYK2KMT2A
SCHEMBL6811570 0.74 TDP1 (0.48) ALDH1A1KMT2AMEN1SMN1; SMN2TSHR
SCHEMBL18146401 0.73 MAOB (0.46) KDM4EALDH1A1GAAHPGDKMT2A
SCHEMBL11490765 0.73 GAA (0.58) KDM4EALDH1A1GAAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7709479-B1 Quinazoline derivatives and their use as pharmaceuticals ASTRAZENECA (SE) 2010-05-04 US disclosed
CN-1391562-A Quinazoline derivatives as medicaments ASTRAZENECA AB (SE) 2003-01-15 CN disclosed
EP-1218354-A1 QUINAZOLINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS AstraZeneca AB (SE) 2002-07-03 EP disclosed
WO-2001021596-A1 QUINAZOLINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS ASTRAZENECA AB (SE) 2001-03-29 WO disclosed